RespireRx Pharmaceuticals Inc. Contracts & Agreements

RespireRx - Alien Technology Transfer India Private Limited Agreement dated July 29, 2024 (Filed With SEC on August 2, 2024)

RespireRx - Alien Technology Transfer USA Inc. Agreement dated July 29, 2024 (Filed With SEC on August 2, 2024)

RespireRx - Alien Technology Transfer India Private Limited Agreement dated July 2, 2024 (Filed With SEC on July 8, 2024)

RespireRx - Alien Technology Transfer USA Inc. Agreement dated July 2, 2024 (Filed With SEC on July 8, 2024)

RespireRx Demand Promissory Note and Warrant Purchase Agreement with Dariusz Nasiek and Sara Nasiek dated April 10, 2024 (Filed With SEC on April 16, 2024)

RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Demand Promissory Note dated April 10, 2024 (Filed With SEC on April 16, 2024)

RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Warrant dated April 10, 2024 (Filed With SEC on April 16, 2024)

Debt Settlement Agreement in the amount of $85,500 dated January 30, 2024 related to Former Officer Noted dated on or about February 2, 2016 (Filed With SEC on February 2, 2024)

Debt Settlement Agreement in the amount of $40,500 dated January 30, 2024 related to Former Officer Noted dated on or about September 22, 2016 (Filed With SEC on February 2, 2024)

Debt Settlement Agreement in the amount of $54,000 dated January 30, 2024 related to Former Officer Noted dated on or about April 10, 2018 (Filed With SEC on February 2, 2024)

Amended and Restated Convertible Note due January 30, 2025 in the amount of $85,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)

Amended and Restated Convertible Note due January 30, 2025 in the amount of $40,500 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)

Amended and Restated Convertible Note due January 30, 2025 in the amount of $54,000 between RespireRx Pharmaceuticals Inc. and one Institutional Investor (Filed With SEC on February 2, 2024)

Consulting Agreement between RespireRx Pharmaceuticals Inc. and Ponto Ventures LLC dated December 6, 2023 (Filed With SEC on December 11, 2023)

Agreement between RespireRx Pharmaceuticals Inc. and Seven Life Sciences dated December 6, 2023 (Filed With SEC on December 11, 2023)

License Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (Filed With SEC on August 9, 2023)

Sublicense Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (Filed With SEC on August 9, 2023)

Stock Transfer Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (Filed With SEC on August 9, 2023)

Master Intercompany Services Agreement between RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd dated August 3, 2023 (Filed With SEC on August 9, 2023)

Letter Agreement between Viridian Capital Advisors and RespireRx Pharmaceuticals Inc. dated May 11, 2023 (Filed With SEC on May 24, 2023)

RespireRx Demand Promissory Note and Warrant Purchase Agreement Arnold Lippa Family Trust of 2007 dated May 22, 2023 (Filed With SEC on May 24, 2023)

RespireRx-Arnold Lippa Family Trust of 2007 Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)

RespireRx-Arnold Lippa Family Trust of 2007 Warrant dated May 22, 2023 (Filed With SEC on May 24, 2023)

RespireRx Demand Promissory Note and Warrant Purchase Agreement Marc M. Radin PC dated May 22, 2023 (Filed With SEC on May 24, 2023)

RespireRx-Marc M. Radin PC Demand Promissory Note dated May 22, 2023 (Filed With SEC on May 24, 2023)

RespireRx-Marc M. Radin PC Warrant dated May 22, 2023 (Filed With SEC on May 24, 2023)

Description of Registrants Securities (Filed With SEC on April 17, 2023)

Second Amendment to Respirerx -University Of Illinois Exclusive License Agreement (Filed With SEC on January 23, 2023)

Securities Purchase Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms... (Filed With SEC on November 17, 2022)

Piggy-back Registrations Rights Agreement template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds,... (Filed With SEC on November 17, 2022)

Promissory Note template for August 22, 2022 three convertible note financings totaling $105,556 in principal amount and $95,000 of net proceeds, identical in terms except as to... (Filed With SEC on November 17, 2022)

Description of Registrants Securities (Filed With SEC on April 15, 2022)

Securities Purchase Agreement dated April 14, 2022, between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)

Piggy-back Registration Rights Agreement dated April 14, 2022 between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)

Promissory Note dated, April 14, 2022 (Filed With SEC on April 15, 2022)

Common Stock Purchase Warrant, dated April 14, 2022 (Filed With SEC on April 15, 2022)

Description of Registrants Securities (Filed With SEC on April 15, 2021)

Letter Agreement, dated October 21, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 26, 2020)

Letter Agreement, dated October 23, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 26, 2020)

Escrow Deposit Agreement, dated October 23, 2020, between RespireRx Pharmaceuticals Inc. and Signature Bank (Filed With SEC on October 26, 2020)

Agreement and Plan of Merger, dated as of August 10, 2012, by and among Cortex Pharmaceuticals, Inc., Pier Acquisition Corp. and Pier Pharmaceuticals, Inc (Filed With SEC on October 14, 2020)

Placement Agency Agreement, dated August 24, 2007, by and between Cortex Pharmaceuticals, Inc. and JMP Securities LLC and Rodman and Renshaw, LLC, Form of Subscription Agreement... (Filed With SEC on October 14, 2020)

Placement Agency Agreement, dated April 13, 2009, by and between the Company and Rodman & Renshaw, LLC, Form of Securities Purchase Agreement and Form of Common Stock Purchase... (Filed With SEC on October 14, 2020)

Cortex Pharmaceuticals, Inc. 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Form of Notice of Grant of Stock Options and Option Agreement under the Companys 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Form of Incentive/Non-qualified Stock Option Agreement under the Companys 2006 Stock Incentive Plan (Filed With SEC on October 14, 2020)

Amendment No. 1 to the Companys 2006 Stock Incentive Plan, dated May 9, 2007 (Filed With SEC on October 14, 2020)

Amendment No. 2 to the Companys 2006 Stock Incentive Plan, effective as of June 5, 2009 (Filed With SEC on October 14, 2020)

Amendment No. 3 to the Companys 2006 Stock Incentive Plan, effective May 19, 2010 (Filed With SEC on October 14, 2020)

Patent License Agreement between the Company and the University of Alberta, dated as of May 9, 2007 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 29, 2009, by and between the Company and the Investors named therein (Filed With SEC on October 14, 2020)

Asset Purchase Agreement, dated March 15, 2011, by and between the Company and Biovail Laboratories International SRL (Filed With SEC on October 14, 2020)

Patent Assignment and Option and Amended and Restated Agreement, dated June 10, 2011, between the Company and Les Laboratoires Servier (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated January 15, 2010, by and between the Company and Samyang Optics Co., Ltd., including a form of Convertible Promissory Note attached as Exhibit... (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated October 20, 2011, by and between the Company and Samyang Value Partners Co., Ltd., including the Common Stock Purchase Warrant attached as... (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated June 25, 2012, by and between the Company and Samyang Optics Co., Ltd., including a form of Secured Promissory Note attached as Exhibit A... (Filed With SEC on October 14, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 14, 2020)

Cortex Pharmaceuticals, Inc. 2014 Equity, Equity-Linked and Equity Derivative Incentive Plan, established March 14, 2014 (Filed With SEC on October 14, 2020)

Exclusive License Agreement, dated as of June 27, 2014, by and between the Board of Trustees of the University of Illinois, a body corporate and politic of the State of Illinois,... (Filed With SEC on October 14, 2020)

Standard Agreement for Submitting Compounds for Preclinical Pharmacological, Pharmacokinetic and Toxicological Evaluation, dated October 19, 2015, by and between the National... (Filed With SEC on October 14, 2020)

Form of Non-Statutory Stock Option Award Agreement (Filed With SEC on October 14, 2020)

Form of Incentive Stock Option Award Agreement (Filed With SEC on October 14, 2020)

Form of Restricted Stock Award Agreement (Filed With SEC on October 14, 2020)

Release Agreement, dated September 2, 2014, between the Company and the Institute for the Study of Aging Inc (Filed With SEC on October 14, 2020)

Form of Convertible Note and Warrant Agreement, including a form of 10% Convertible Note due September 15, 2012 attached as Exhibit A thereto and a Form of Warrant to Purchase... (Filed With SEC on October 14, 2020)

Demand Promissory Note, dated June 16, 2015, held by Arnold S. Lippa on behalf of the Company (Filed With SEC on October 14, 2020)

Form of Demand Promissory Note (Filed With SEC on October 14, 2020)

Form of Warrant to Purchase Common Stock (Filed With SEC on October 14, 2020)

2015 Stock and Stock Option Plan, dated June 30, 2015 (Filed With SEC on October 14, 2020)

Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

First Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Form of Non-Statutory Stock Option Award Agreement (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and James S. J. Manuso (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Robert N. Weingarten (Filed With SEC on October 14, 2020)

Employment Agreement, dated August 18, 2015, between the Company and Jeff E. Margolis (Filed With SEC on October 14, 2020)

Form of Second Amended and Restated Common Stock and Warrant Purchase Agreement (Filed With SEC on October 14, 2020)

Form of Common Stock and Warrant Purchase Agreement, including a Form of Warrant to Purchase Common Stock attached as Exhibit A thereto (Filed With SEC on October 14, 2020)

Form of Exchange Agreement, including a Form of New Warrant attached as Exhibit A thereto (Filed With SEC on October 14, 2020)

Form of Exchange Agreement (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Amendment No. One of the Employment Agreement of Jeff E. Margolis, effective July 1, 2017 (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Second Amendment of the Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Form of Demand Promissory Note (Filed With SEC on October 14, 2020)

Form of Note Exchange Agreement (Filed With SEC on October 14, 2020)

Form of Purchase Agreement (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Development and Supply Agreement, dated September 4, 2018 (Filed With SEC on October 14, 2020)

Form of Convertible Promissory Note (including a Form of Warrant) (Filed With SEC on October 14, 2020)

Form of Convertible Promissory Note (including the Form of Warrant) (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated April 24, 2019, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated April 24, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated May 17, 2019, between RespireRx Pharmaceuticals Inc. and Crown Bridge Partners, LLC (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated May 17, 2019 (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated May 17, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated August 19, 2019, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated August 19, 2019 (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated August 19, 2019 (Filed With SEC on October 14, 2020)

Settlement Agreement and Release, dated August 21, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated October 22, 2019, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)

10% Convertible Note, dated October 22, 2019 (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated October 22, 2019 (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated November 4, 2019, between RespireRx Pharmaceuticals Inc. and Odyssey Funding, LLC (Filed With SEC on October 14, 2020)

RespireRx Pharmaceuticals Inc. 10% Convertible Redeemable Note due November 4, 2020, dated November 4, 2019 (Filed With SEC on October 14, 2020)

First Amendment to Settlement Agreement and Release, dated as of December 16, 2019, between RespireRx Pharmaceuticals Inc. and Salamandra, LLC (Filed With SEC on October 14, 2020)

Company Option Agreement, dated as of March 2, 2020, by and between the UWM Research Foundation, Inc. and RespireRx Pharmaceuticals Inc (Filed With SEC on October 14, 2020)

Form of Exchange Agreement (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated April 15, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated April 15, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated June 7, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated June 7, 2020, in favor of Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 2, 2020, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Convertible Promissory Note, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated July 2, 2020, in favor of FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)

Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)

Exchange Agreement, dated July 13, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Employment Agreement, dated May 6, 2020, between RespireRx Pharmaceuticals Inc.and Timothy Jones (Filed With SEC on October 14, 2020)

Amendment No. 1 to Employment Agreement of Timothy Jones, effective July 31, 2020 (Filed With SEC on October 14, 2020)

Fourth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Fifth Amendment of Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on October 14, 2020)

Equity Purchase Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)

Registration Rights Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)

8% Fixed Promissory Note, dated July 28, 2020, in favor of White Lion Capital, LLC (Filed With SEC on October 14, 2020)

Patent License Agreement, dated as of August 1, 2020, by and between the University of Wisconsin-Milwaukee Research Foundation, Inc. and RespireRx Pharmaceuticals Inc (Filed With SEC on October 14, 2020)

Securities Purchase Agreement, dated July 30, 2020, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)

10% Convertible Note, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)

Common Stock Purchase Warrant, dated July 30, 2020, in favor of EMA Financial, LLC (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Timothy Jones (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Jeff Eliot Margolis (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Arnold S. Lippa (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Marc Radin PC (Filed With SEC on October 14, 2020)

Exchange Agreement, dated September 30, 2020, between RespireRx Pharmaceuticals Inc. and Patent Network Law Group (Filed With SEC on October 14, 2020)

Amendment No. 1 to 8% Fixed Promissory Note, dated September 30, 2020 (Filed With SEC on October 14, 2020)

Description of Registrants Securities (Filed With SEC on April 14, 2020)

Development and Supply Agreement, dated September 4, 2018, between the Company and Noramco, Inc (Filed With SEC on November 16, 2018)

Form of Purchase Agreement (including the Form of Warrant) (Filed With SEC on September 13, 2018)

Second Amendment of the Amended and Restated RespireRx Pharmaceuticals Inc. 2015 Stock and Stock Option Plan (Filed With SEC on December 14, 2017)

Addendum No. 1 to Form of Non-Statutory Stock Option Award Agreement under the Amended and Restated 2015 Stock and Stock Option Plan (Filed With SEC on December 14, 2017)

Amendment No. One of the Employment Agreement of Jeff E. Margolis, effective July 1, 2017 (Filed With SEC on November 20, 2017)

COMMONSTOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on August 30, 2017)

COMMONSTOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on March 16, 2017)

FIRSTAMENDMENT OF AMENDEDAND RESTATED RESPIRERX PHARMACEUTICALS INC. 2015STOCK AND STOCK OPTION PLAN (Filed With SEC on January 23, 2017)

COMMONSTOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 5, 2017)

FORMOF DEMANDPROMISSORY NOTE (Filed With SEC on September 28, 2016)

FORMOF WARRANTTO PURCHASE COMMON STOCK RespireRxPharmaceuticals Inc. (Filed With SEC on September 28, 2016)

EXCHANGEAGREEMENT (Filed With SEC on April 12, 2016)

EXCHANGEAGREEMENT (Filed With SEC on April 11, 2016)

AMENDEDAND RESTATED RESPIRERX PHARMACEUTICALS INC. 2015STOCK AND STOCK OPTION PLAN (Filed With SEC on April 6, 2016)

FORMOF DEMANDPROMISSORY NOTE (Filed With SEC on February 3, 2016)

FORM OF WARRANTTO PURCHASE COMMON STOCK RespireRxPharmaceuticals Inc. (Filed With SEC on February 3, 2016)

COMMON STOCK AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 11, 2016)

EMPLOYMENTAGREEMENT (Filed With SEC on November 2, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on November 2, 2015)

EMPLOYMENTAGREEMENT (Filed With SEC on November 2, 2015)

SECOND AMENDED AND RESTATED COMMON STOCKAND WARRANT PURCHASE AGREEMENT (Filed With SEC on August 31, 2015)

EMPLOYMENTAGREEMENT (Filed With SEC on August 19, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on August 19, 2015)

EMPLOYMENTAGREEMENT (Filed With SEC on August 19, 2015)

CORTEXPHARMACEUTICALS, INC. 2015STOCK AND STOCK OPTION PLAN (Filed With SEC on July 8, 2015)

FORMOF NON-STATUTORY STOCK OPTION AWARD AGREEMENT (Filed With SEC on July 8, 2015)

DEMANDPROMISSORY NOTE (Filed With SEC on June 19, 2015)

CONVERTIBLENOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on November 12, 2014)

CortexPharmaceuticals, Inc. 126 Valley Road, Suite C, Glen Rock, NJ 07452 www.cortexpharm.com (Filed With SEC on September 5, 2014)

FORMOF NON-STATUTORY STOCK OPTION AWARD AGREEMENT (Filed With SEC on July 23, 2014)

FORMOF INCENTIVE STOCK OPTION AWARD AGREEMENT (Filed With SEC on July 23, 2014)

FORMOF RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on July 23, 2014)

EXCLUSIVELICENSE AGREEMENT (Filed With SEC on July 1, 2014)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on March 24, 2014)

CORTEX PHARMACEUTICALS, INC. 2014 EQUITY, EQUITY-LINKED AND EQUITYDERIVATIVE INCENTIVE PLAN (Filed With SEC on March 24, 2014)

STANDARD MULTI-TENANT OFFICE LEASEGROSS AIR COMMERCIAL REAL ESTATE ASSOCIATION (Filed With SEC on August 16, 2012)

CORTEX PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 16, 2012)

AGREEMENT AND PLAN OF MERGER BY AND AMONG CORTEX PHARMACEUTICALS, INC., PIER ACQUISITION CORP. AND PIER PHARMACEUTICALS, INC. AUGUST 10, 2012 TABLE OF CONTENTS (Filed With SEC on August 16, 2012)

CORTEX PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 30, 2012)

Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on September 7, 2011)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 7, 2011)

COMMON STOCK PURCHASE WARRANT CORTEX PHARMACEUTICALS, INC. (Filed With SEC on September 7, 2011)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2011)

SEVENTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 8, 2011)

ASSETPURCHASE AGREEMENT BY AND BETWEEN CORTEX PHARMACEUTICALS, INC., AS BUYER, AND BIOVAIL LABORATORIES INTERNATIONAL SRL, AS SELLER TABLE OF CONTENTS (Filed With SEC on May 23, 2011)

FIFTH AMENDMENT TO LICENSE AGREEMENT 1993-04-0412 BETWEEN CORTEX PHARMACEUTICALS AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Filed With SEC on March 21, 2011)

AMENDMENT TO LICENSE AGREEMENT 1993-04-0412 BETWEEN CORTEXPHARMACEUTICALS AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Filed With SEC on August 30, 2010)

SIXTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on August 18, 2010)

CORTEX PHARMACEUTICALS, INC. AMENDMENT NO. 3 TO 2006 STOCK INCENTIVE PLAN (Filed With SEC on May 25, 2010)

ASSET PURCHASE AGREEMENT BY AND BETWEEN BIOVAIL LABORATORIES INTERNATIONAL SRL, AS BUYER, AND CORTEX PHARMACEUTICALS, INC., AS SELLER TABLE OF CONTENTS (Filed With SEC on May 17, 2010)

LICENSE AGREEMENT (Filed With SEC on May 17, 2010)

CORTEX PHARMACEUTICALS, INC. SECURITIES PURCHASEAGREEMENT (Filed With SEC on January 21, 2010)

CORTEX PHARMACEUTICALS, INC. AMENDMENT NO. 2 TO 2006 STOCK INCENTIVE PLAN (Filed With SEC on August 14, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 30, 2009)

1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### (Filed With SEC on April 17, 2009)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 17, 2009)

COMMON STOCK PURCHASE WARRANT CORTEX PHARMACEUTICALS, INC. (Filed With SEC on April 17, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2008)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2008)

AMENDMENT NO. 1 TO SEVERANCE AGREEMENT (Filed With SEC on December 23, 2008)

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 17, 2008)

FOURTH AMENDMENT TO THAT LEASE BY AND BETWEEN THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, as Landlord and CORTEX PHARMACEUTICALS, INC., asTenant ORIGINAL LEASE DATE: JANUARY... (Filed With SEC on June 10, 2008)

AMENDMENT NO. 3 TO CONSULTING AGREEMENT (Filed With SEC on May 8, 2008)

CONFIDENTIAL PORTIONS OMITTED PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF1934 Patent License Agreement between the University of Alberta and Cortex Pharmaceuticals,... (Filed With SEC on March 17, 2008)

CORTEX PHARMACEUTICALS, INC. 7,075,000 Shares Warrants to Purchase 2,830,000 Shares Common Stock (Filed With SEC on August 27, 2007)

Subscription Agreement (Filed With SEC on August 27, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of Cortex Pharmaceuticals, Inc. (Filed With SEC on August 27, 2007)

AMENDMENT NO. 2 TO CONSULTING AGREEMENT (Filed With SEC on August 9, 2007)

CORTEX PHARMACEUTICALS, INC. AMENDMENT NO. 1 TO 2006 STOCK INCENTIVE PLAN (Filed With SEC on May 15, 2007)

NEGATIVE EQUITY AGREEMENT (Filed With SEC on May 10, 2007)

LEAVE OF ABSENCE AGREEMENT (Filed With SEC on March 15, 2007)

CORTEX PHARMACEUTICALS, INC. 5,021,427 Shares Warrants to Purchase 3,263,927 Shares (Filed With SEC on January 19, 2007)

Subscription Agreement (Filed With SEC on January 19, 2007)

COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of Cortex Pharmaceuticals, Inc. (Filed With SEC on January 19, 2007)

Shares (Filed With SEC on August 8, 2006)

CORTEX PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT UNDER (Filed With SEC on August 8, 2006)

THIRD AMENDMENT TO THAT LEASE BY AND BETWEEN THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, as Landlord (Filed With SEC on August 8, 2006)

AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on May 22, 2006)

CORTEX PHARMACEUTICALS, INC. 2006 STOCK INCENTIVE PLAN (Filed With SEC on May 11, 2006)

CORTEX PHARMACEUTICALS, INC. Non-Qualified Stock Option Agreement (Filed With SEC on May 9, 2006)

THIRD AMENDMENT TO EMPLOYMENT AGREEMENT DATED OCTOBER 29, 2002 BETWEEN CORTEX PHARMACEUTICALS AND ROGER G. STOLL, Ph.D. (Filed With SEC on August 17, 2005)

DIRECTORS & EXECUTIVE OFFICERS (Filed With SEC on March 21, 2005)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 20, 2004)

CONSULTING AGREEMENT (Filed With SEC on November 15, 2004)

SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED OCTOBER 29, 2002 (Filed With SEC on November 15, 2004)

SECOND AMENDMENT (Filed With SEC on September 27, 2004)

CORTEX PHARMACEUTICALS, INC. (Incentive or Non-qualified) Stock Option Agreement (Filed With SEC on September 27, 2004)

CORTEX PHARMACEUTICALS, INC. RESTRICTED STOCK AWARD AGREEMENT UNDER 1996 STOCK INCENTIVE PLAN (Filed With SEC on September 27, 2004)

AMENDMENT TO EMPLOYMENT AGREEMENT DATED MAY 17, 2000 BETWEEN CORTEX PHARMACEUTICALS AND JAMES H. COLEMAN (Filed With SEC on September 27, 2004)

AMENDMENT TO EMPLOYMENT AGREEMENT DATED JUNE 5, 1995, BETWEEN CORTEX PHARMACEUTICALS AND GARY A. ROGERS, Ph.D. (Filed With SEC on September 27, 2004)

CONFIDENTIAL PORTIONS OMITTED PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 EXCLUSIVE LICENSE AGREEMENT between CORTEX PHARMACEUTICALS, INC. (Filed With SEC on February 12, 2004)

CONFIDENTIAL PORTIONS OMITTED PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934 RESTATED AMENDMENT N°2 TO THE COLLABORATION RESEARCH (Filed With SEC on February 12, 2004)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 13, 2004)

AMENDMENT TO EMPLOYMENT AGREEMENT DATED OCTOBER 29, 2002 BETWEEN CORTEX PHARMACEUTICALS AND ROGER G. STOLL, Ph.D.. (Filed With SEC on September 19, 2003)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 22, 2003)

CORTEX PHARMACEUTICALS, INC. (Filed With SEC on November 14, 2002)

EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2002)

Category

Industry

Companies

Contracts

RespireRx Pharmaceuticals Inc. Contracts & Agreements